0

Levetiracetam Related Compound A

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP102767317
CAS102767-31-7
Structure
MDL NumberMFCD09955129
Molecular Weight206.67
InChI KeyQBJNYRYTZPBHFT-LURJTMIESA-N
REAXYS Number13476773
DescriptionUnited States Pharmacopeia (USP) Reference Standard
Formneat
Gradepharmaceutical primary standard
Size20MG
1

Antimyoclonic Effect of Levetiracetam

P Genton, P Gélisse

Epileptic Disord. 2000 Dec;2(4):209-12.

PMID: 11174151

1

Characterization of the Binding of [3H]-SB-204269, a Radiolabelled Form of the New Anticonvulsant SB-204269, to a Novel Binding Site in Rat Brain Membranes

H J Herdon, J C Jerman, T O Stean, D N Middlemiss, W N Chan, A K Vong, J M Evans, M Thompson, N Upton

Br J Pharmacol. 1997 Aug;121(8):1687-91.

PMID: 9283704

1

Development of a SPE-HPLC-MS/MS Method for the Determination of Most Prescribed Pharmaceuticals and Related Metabolites in Urban Sewage Samples

Robert Gurke, Julia Rossmann, Sara Schubert, Tobias Sandmann, Martin Rößler, Reinhard Oertel, Joachim Fauler

J Chromatogr B Analyt Technol Biomed Life Sci. 2015 May 15;990:23-30.

PMID: 25841203

1

The Novel Antiepileptic Drug Levetiracetam (Ucb L059) Appears to Act via a Specific Binding Site in CNS Membranes

M Noyer, M Gillard, A Matagne, J P Hénichart, E Wülfert

Eur J Pharmacol. 1995 Nov 14;286(2):137-46.

PMID: 8605950

1

The Synaptic Vesicle Protein SV2A Is the Binding Site for the Antiepileptic Drug Levetiracetam

Berkley A Lynch, Nathalie Lambeng, Karl Nocka, Patricia Kensel-Hammes, Sandra M Bajjalieh, Alain Matagne, Bruno Fuks

Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9861-6.

PMID: 15210974

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode